(RAYC) Rayliant Quantamental China - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00774Q1976
RAYC: Common Stock, Preferred Stock, ADRs, REITs, ETFs
The Rayliant Quantamental China Equity ETF (NYSE ARCA:RAYC) is an actively managed exchange-traded fund that focuses on investing in Chinese equity securities, with a minimum of 80% of its net assets allocated to this asset class under normal market conditions. The funds investment universe encompasses a broad range of equity securities, including common stock, preferred stock, American Depositary Receipts (ADRs), and Real Estate Investment Trusts (REITs), with no restrictions on market capitalization.
The funds investment strategy is characterized by its flexibility, as it may invest in various sectors, potentially concentrating its investments in specific industries such as financials or consumer discretionary. Additionally, the fund may utilize exchange-traded funds (ETFs) to manage cash positions and engage in securities lending to enhance returns. As a non-diversified fund, RAYC may exhibit a higher level of volatility compared to its diversified counterparts.
From a technical analysis perspective, the current price of RAYC is $14.73, with short-term moving averages (SMA20: $14.31, SMA50: $14.16) indicating a positive trend. The long-term moving average (SMA200: $14.00) also supports this upward trajectory. The Average True Range (ATR) of 0.12, equivalent to 0.84%, suggests relatively low volatility. Given the current technical setup and fundamental data, including the funds Assets Under Management (AUM) of $18.44M USD, a potential forecast could be that RAYC continues its upward trend, potentially reaching the upper end of its 52-week range or even surpassing it, driven by the underlying momentum in Chinese equities and the funds active management strategy.
Forecasting further, if the current trend persists and the funds AUM continues to grow, RAYC may attract more investors seeking exposure to the Chinese market, potentially driving the price higher. However, its crucial to monitor the funds sector concentration and overall market conditions, as these factors can significantly impact its performance. A break above the 52-week high of $18.80 could signal further upside potential, while a decline below the SMA50 might indicate a reversal in the trend.
Additional Sources for RAYC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
RAYC ETF Overview
Market Cap in USD | 17m |
Category | China Region |
TER | 0.80% |
IPO / Inception | 2020-12-30 |
RAYC ETF Ratings
Growth Rating | -33.8 |
Fundamental | - |
Dividend Rating | 65.9 |
Rel. Strength | 0.64 |
Analysts | - |
Fair Price Momentum | 13.54 USD |
Fair Price DCF | - |
RAYC Dividends
Dividend Yield 12m | 4.04% |
Yield on Cost 5y | 2.53% |
Annual Growth 5y | 28.57% |
Payout Consistency | 98.9% |
Payout Ratio | % |
RAYC Growth Ratios
Growth Correlation 3m | 38.9% |
Growth Correlation 12m | 53.2% |
Growth Correlation 5y | -84.8% |
CAGR 5y | -9.52% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | 0.09 |
Alpha | 5.69 |
Beta | 0.313 |
Volatility | 18.24% |
Current Volume | 1k |
Average Volume 20d | 1.9k |
As of June 16, 2025, the stock is trading at USD 14.71 with a total of 986 shares traded.
Over the past week, the price has changed by -0.10%, over one month by +1.14%, over three months by +2.36% and over the past year by +12.17%.
Probably not. Based on ValueRay´s Analyses, Rayliant Quantamental China (NYSE ARCA:RAYC) is currently (June 2025) not a good stock to buy. It has a ValueRay Growth Rating of -33.79 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RAYC is around 13.54 USD . This means that RAYC is currently overvalued and has a potential downside of -7.95%.
Rayliant Quantamental China has no consensus analysts rating.
According to our own proprietary Forecast Model, RAYC Rayliant Quantamental China will be worth about 14.8 in June 2026. The stock is currently trading at 14.71. This means that the stock has a potential upside of +0.68%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 14.8 | 0.7% |